XML 86 R70.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Details) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated compensation expense $ 1,822,000 $ (1,161,000) $ 2,448,000
Weighted Average Price at Grant      
Equity-based compensation 5,182,000 (166,000) 721,000
Additional Paid-in Capital      
Weighted Average Price at Grant      
Equity-based compensation 5,182,000 (166,000) 721,000
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated compensation expense 2,739,000 $ 1,209,000 $ 895,000
Unamortized cost $ 3,900,000    
Unamortized cost, period of recognition 2 years 9 months 18 days    
Weighted average period for recognition 2 years 2 months 12 days    
Shares      
Outstanding at beginning of year (in shares) 420,000 360,000 140,000
Granted (in shares) 257,000 198,000 309,000
Vested (in shares) (229,000) (131,000) (84,000)
Forfeited (in shares) (7,000) (7,000) (5,000)
Outstanding at end of year (in shares) 441,000 420,000 360,000
Weighted Average Price at Grant      
Outstanding at beginning of year (in dollars per share) $ 11.87 $ 12.90 $ 16.01
Granted (in dollars per share) 9.90 10.78 12.34
Vested (in dollars per share) 11.54 13.05 15.98
Forfeited (in dollars per share) 10.50 11.81 13.82
Outstanding at end of year (in dollars per share) $ 10.91 $ 11.87 $ 12.90
Restricted Stock [Member] | Executive Officer [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated compensation expense $ 640,000    
Restricted Stock [Member] | Advisory Services Fee [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated compensation expense 2,277,000 $ 916,000 $ 597,000
Restricted Stock [Member] | Management Fees [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated compensation expense 219,000 92,000 71,000
Restricted Stock [Member] | Corporate General and Administrative Expense [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated compensation expense 243,000 $ 201,000 $ 227,000
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unamortized cost $ 2,000,000    
Unamortized cost, period of recognition 2 years    
Weighted average period for recognition 1 year 8 months 12 days    
Shares      
Outstanding at beginning of year (in shares) 381,000 417,000 155,000
Granted (in shares) 197,000 119,000 262,000
Forfeited (in shares) (262,000) (155,000) 0
Outstanding at end of year (in shares) 316,000 381,000 417,000
Weighted Average Price at Grant      
Outstanding at beginning of year (in dollars per share) $ 11.97 $ 14.80 $ 18.40
Granted (in dollars per share) 13.43 10.42 12.67
Forfeited (in dollars per share) 12.67 18.40 0.00
Outstanding at end of year (in dollars per share) $ 12.29 $ 11.97 $ 14.80
Service period 3 years    
Performance Shares [Member] | Minimum [Member]      
Weighted Average Price at Grant      
Award performance target 0.00%    
Performance Shares [Member] | Maximum [Member]      
Weighted Average Price at Grant      
Award performance target 200.00%    
Performance Shares [Member] | Executive Officer [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated compensation expense $ 1,600,000    
Performance Shares [Member] | Advisory Services Fee [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Allocated compensation expense $ 2,443,000 $ (1,375,000)  
Performance Shares [Member] | Additional Paid-in Capital | Advisory Services Fee [Member]      
Weighted Average Price at Grant      
Equity-based compensation     $ 813,000
Equity Incentive Plan 2013 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Authorized to grant (in shares) 3,250,000    
Shares available for future issuance (in shares) 1,151,669